Compare JSPR & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JSPR | ABLV |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.1M | 39.5M |
| IPO Year | N/A | N/A |
| Metric | JSPR | ABLV |
|---|---|---|
| Price | $2.05 | $0.66 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $21.44 | N/A |
| AVG Volume (30 Days) | ★ 658.5K | 24.8K |
| Earning Date | 02-26-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $114,319,869.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.16 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.39 | $0.59 |
| 52 Week High | $21.27 | $1.77 |
| Indicator | JSPR | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 62.61 | 38.24 |
| Support Level | $1.73 | $0.63 |
| Resistance Level | $1.85 | $0.75 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 97.70 | 13.64 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.